Chopra Daveen 4
4 · Edwards Lifesciences Corp · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Edwards Lifesciences (EW) CVP Daveen Chopra Sells 1,500 Shares
What Happened
Daveen Chopra, CVP, TMTT & Surgical at Edwards Lifesciences, reported the sale of 1,500 shares on May 22, 2026. The shares were disposed at a weighted average price of $84.60 per share for total proceeds of approximately $126,905. The filing lists the transaction as an open-market or private sale (code S); sales are often routine and do not necessarily indicate a change in view about the company.
Key Details
- Transaction date: 2026-05-22
- Type: Sale (S) — reported as open market or private sale
- Price: Weighted average $84.60; executed in multiple trades at prices ranging $84.6002–$84.6050 (see footnote). The reporting person will provide a full breakdown on request.
- Shares sold: 1,500; proceeds ≈ $126,905
- Shares owned after transaction: Not specified in this Form 4 (filing notes it reflects changes in beneficial ownership only)
- Filing: Reported and filed on 2026-05-22 (appears timely)
Context
Insider sales can reflect many reasons (diversification, taxes, personal liquidity) and a single sale is not a clear negative signal by itself. This Form 4 does not show any option exercises, gifts, or 10% owner status; it only reports the change in beneficial ownership from this sale.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-05-22$84.60/sh−1,500$126,905→ 44,324 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.